T2 Biosystems Inc. [NASDAQ: TTOO] gained 15.07% or 0.22 points to close at $1.68 with a heavy trading volume of 10260693 shares. The company report on March 9, 2021 that SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating T2 Biosystems, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors.
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of T2 Biosystems, Inc. (NASDAQ:TTOO).
If you are a shareholder of T2 Biosystems, Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at:.
It opened the trading session at $1.50, the shares rose to $1.77 and dropped to $1.48, the range by which the price of stock traded the whole day. The daily chart for TTOO points out that the company has recorded 33.33% gains over the past six months. However, it is still -630.43% lower than its most recent low trading price.
If we look at the average trading volume of 13.11M shares, TTOO reached to a volume of 10260693 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about T2 Biosystems Inc. [TTOO]:
Alliance Global Partners have made an estimate for T2 Biosystems Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 27, 2021. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on October 08, 2020, representing the official price target for T2 Biosystems Inc. stock.
The Average True Range (ATR) for T2 Biosystems Inc. is set at 0.35, with the Price to Sales ratio for TTOO stock in the period of the last 12 months amounting to 22.61. The Price to Book ratio for the last quarter was 14.00, with the Price to Cash per share for the same quarter was set at 0.23.
Trading performance analysis for TTOO stock
T2 Biosystems Inc. [TTOO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -24.32. With this latest performance, TTOO shares dropped by -45.81% in over the last four-week period, additionally plugging by 33.33% over the last 6 months – not to mention a rise of 212.44% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TTOO stock in for the last two-week period is set at 38.08, with the RSI for the last a single of trading hit 32.94, and the three-weeks RSI is set at 42.11 for T2 Biosystems Inc. [TTOO]. The present Moving Average for the last 50 days of trading for this stock 2.1396, while it was recorded at 1.7440 for the last single week of trading, and 1.5376 for the last 200 days.
T2 Biosystems Inc. [TTOO]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and T2 Biosystems Inc. [TTOO] shares currently have an operating margin of -228.11 and a Gross Margin at -17.37. T2 Biosystems Inc.’s Net Margin is presently recorded at -258.12.
Return on Total Capital for TTOO is now -107.07, given the latest momentum, and Return on Invested Capital for the company is -289.22. When it comes to the capital structure of this company, T2 Biosystems Inc. [TTOO] has a Total Debt to Total Equity ratio set at 639.10. Additionally, TTOO Total Debt to Total Capital is recorded at 86.47, with Total Debt to Total Assets ending up at 70.52. Long-Term Debt to Equity for the company is recorded at 639.10, with the Long-Term Debt to Total Capital now at 86.47.
Receivables Turnover for the company is 4.58 with a Total Asset Turnover recorded at a value of 0.34.T2 Biosystems Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.60 and a Current Ratio set at 5.00.
T2 Biosystems Inc. [TTOO]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, T2 Biosystems Inc. posted -0.22/share EPS, while the average EPS was predicted by analysts to be reported at -0.23/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 4.30%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TTOO.
An analysis of insider ownership at T2 Biosystems Inc. [TTOO]
There are presently around $36 million, or 14.50% of TTOO stock, in the hands of institutional investors. The top three institutional holders of TTOO stocks are: VANGUARD GROUP INC with ownership of 6,185,575, which is approximately 15.307% of the company’s market cap and around 0.30% of the total institutional ownership; GOLDMAN SACHS GROUP INC, holding 4,358,817 shares of the stock with an approximate value of $7.32 million in TTOO stocks shares; and BLACKROCK INC., currently with $3.7 million in TTOO stock with ownership of nearly 0.023% of the company’s market capitalization.
Positions in T2 Biosystems Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 39 institutional holders increased their position in T2 Biosystems Inc. [NASDAQ:TTOO] by around 4,572,158 shares. Additionally, 23 investors decreased positions by around 1,392,512 shares, while 16 investors held positions by with 15,436,289 shares. The mentioned changes placed institutional holdings at 21,400,959 shares, according to the latest SEC report filing. TTOO stock had 20 new institutional investments in for a total of 1,559,069 shares, while 11 institutional investors sold positions of 656,008 shares during the same period.